Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashburn, D.
Right arrow Articles by Ho-Yen, D. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashburn, D.
Right arrow Articles by Ho-Yen, D. O.

Molecular Pathology, Vol 51, Issue 2 105-109, Copyright © 1998 by Journal of Clinical Pathology


ARTICLES

Improved diagnosis of reactivated toxoplasmosis

D Ashburn, MM Davidson, AW Joss, TH Pennington and DO Ho-Yen
Scottish Toxoplasma Reference Laboratory, Microbiology Department, Raigmore Hospital NHS Trust, Inverness, UK.

AIMS: To identify antigens detected by western blotting in primary Toxoplasma gondii infection and determine their role in diagnosis of reactivated toxoplasmosis. METHODS: Twenty three immunocompromised patients were tested by IgG western blotting. Patients were grouped retrospectively. Group 1 comprised 15 human immunodeficiency (HIV)/AIDS patients and included: group 1A (six patients with clinical and/or serological evidence of reactivation), group 1B (five patients with clinical evidence only), and group 1C (four asymptomatic patients). Group 2 comprised eight non-HIV/AIDS immunocompromised patients with clinical and/or serological evidence of reactivation. Immunocompetent patients (n = 23) with primary toxoplasmosis were a control group used to determine the progression of the antigens detected. RESULTS: In primary toxoplasmosis, antibodies against 6, 20, 22, 23, 25, 28, 29, and 36 kDa antigens predominated. Detection of four or more of the 6, 20, 22, 23, 25, and 36 kDa antigens was considered to be western blot positive. In two group 1A patients, western blotting indicated past infection. During reactivation, this reverted to being western blot positive. Three other group 1A patients were western blot positive. In three of five group 1B patients, western blot positive results improved serological diagnosis of reactivated toxoplasmosis (p < 0.05). In two of five group 1B patients and all four group 1C patients, western blot indicated past infection. In group 2, two of eight patients reverted from a pattern of past infection to western blot positive. Five other patients from group 2 were western blot positive. CONCLUSIONS: Detection of some low molecular weight antigens is diagnostic of reactivated toxoplasmosis. These antigens can be detected even with normal dye test titres and their detection improves the diagnosis of reactivated toxoplasmosis. They might be the result of the release of bradyzoites from ruptured tissue cysts.


This article has been cited by other articles:


Home page
CVIHome page
C. Leport, J. Franck, G. Chene, F. Derouin, J.-L. Ecobichon, S. Pueyo, J. M. Miro, B. J. Luft, P. Morlat, H. Dumon, et al.
Immunoblot Profile as Predictor of Toxoplasmic Encephalitis in Patients Infected with Human Immunodeficiency Virus
Clin. Vaccine Immunol., May 1, 2001; 8(3): 579 - 584.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
D Ashburn, R Evans, J M W Chatterton, A W L Joss, and D O Ho-Yen
Toxoplasma dye test using cell culture derived tachyzoites
J. Clin. Pathol., August 1, 2000; 53(8): 630 - 633.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
D O Ho-Yen, D J Chapman, and D Ashburn
Immunoblotting can help the diagnosis of ocular toxoplasmosis
Mol. Pathol., June 1, 2000; 53(3): 155 - 158.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.